# Liquid–liquid phase separation couples MKRN2-mediated ubiquitination of CSDE1 with neurodevelopmental disorders

**Authors:** Zi Wang, Yaning Han, Peng Yang, Caiwei Jia, Chuanyin Li, Shilin Yuan, Pengfei Wei, Ronggui Hu

PMC · DOI: 10.3389/fncel.2026.1757304 · Frontiers in Cellular Neuroscience · 2026-02-11

## TL;DR

This study shows how MKRN2 regulates CSDE1 through ubiquitination and phase separation, linking these processes to autism-related behaviors in mice.

## Contribution

The study identifies a novel LLPS-coupled ubiquitination mechanism involving MKRN2 and CSDE1 in neurodevelopmental disorders.

## Key findings

- MKRN2 ubiquitinates CSDE1 at four lysine residues, and this process is essential for condensate formation.
- Mkrn2-knockout mice display sex-specific social behavior abnormalities resembling autism-spectrum disorder.
- CSDE1 regulates ASD-associated mRNAs, connecting condensate dynamics to synaptic plasticity deficits.

## Abstract

Makorin-2 (MKRN2) is an E3 ubiquitin ligase involved in multiple biological processes, yet its role in neurological disorders remains poorly understood. This study aims to elucidate how MKRN2 regulates the RNA-binding protein CSDE1—a molecule linked to autism-related genes—and to explore the functional implications of this interaction in neurodevelopment.

Using mass-spectrometry screening, we identified CSDE1 as a direct substrate of MKRN2. Ubiquitination sites were validated through mutagenesis of conserved lysine residues. Liquid–liquid phase separation (LLPS) assays were performed in HEK293 and SH-SY5Y cells, and behavioral phenotypes were assessed in Mkrn2-knockout mice. Statistical analyses included appropriate tests for comparing ubiquitination levels, condensate formation, and social behavior outcomes.

MKRN2 mediates CSDE1 ubiquitination at four lysine residues (K81, K91, K208, K727). Deletion of MKRN2 or mutation of these sites abolished ubiquitination. MKRN2 and CSDE1 formed co-localized condensates via LLPS, which was disrupted by functional impairment of either protein. Mkrn2-knockout mice exhibited sex-specific social abnormalities—increased sociability in males and social withdrawal in females—recapitulating autism-spectrum disorder (ASD) heterogeneity. We further identified MARK1 and HNRNPUL2, ASD-associated mRNAs, as ubiquitination-dependent targets of CSDE1, linking aberrant condensate dynamics to synaptic plasticity deficits.

Our study reveals an LLPS-coupled ubiquitination mechanism by which MKRN2 regulates CSDE1, providing a novel molecular pathway underlying neurodevelopmental disorders. These findings offer new insights for understanding and treating neurological diseases such as ASD.

## Linked entities

- **Genes:** MKRN2 (makorin ring finger protein 2) [NCBI Gene 23609], CSDE1 (cold shock domain containing E1) [NCBI Gene 7812], MARK1 (microtubule affinity regulating kinase 1) [NCBI Gene 4139], HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U like 2) [NCBI Gene 221092]
- **Proteins:** MKRN2 (makorin ring finger protein 2), CSDE1 (cold shock domain containing E1), MARK1 (microtubule affinity regulating kinase 1), HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U like 2)
- **Diseases:** autism-spectrum disorder (MONDO:0005258)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CAPG (capping actin protein, gelsolin like) [NCBI Gene 822] {aka AFCP, HEL-S-66, MCP}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, MKRN2 (makorin ring finger protein 2) [NCBI Gene 23609] {aka HSPC070, RNF62}, Mkrn2 (makorin, ring finger protein, 2) [NCBI Gene 67027] {aka 2610002L04Rik}, HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U like 2) [NCBI Gene 221092] {aka HNRPUL2, SAF-A2}, UBA1 (ubiquitin like modifier activating enzyme 1) [NCBI Gene 7317] {aka A1S9, A1S9T, A1ST, AMCX1, CFAP124, GXP1}, UBE2D1 (ubiquitin conjugating enzyme E2 D1) [NCBI Gene 7321] {aka E2(17)KB1, SFT, UBC4/5, UBCH5, UBCH5A}, MARK1 (microtubule affinity regulating kinase 1) [NCBI Gene 4139] {aka MARK, Par-1c, Par1c}, Mark1 (MAP/microtubule affinity regulating kinase 1) [NCBI Gene 226778] {aka B930025N23Rik, Emk3, Par-1c, mKIAA1477, mPar-1c}, Csde1 (cold shock domain containing E1, RNA binding) [NCBI Gene 229663] {aka D3Jfr1, mKIAA0885, unr}, PAX6 (paired box 6) [NCBI Gene 5080] {aka AN, AN1, AN2, ASGD5, D11S812E, FVH1}, Rnf216 (ring finger protein 216) [NCBI Gene 108086] {aka 2810055G22Rik, F830018F18Rik, TRIAD3, UIP83, Ubce7ip1}, CBLL2 (Cbl proto-oncogene like 2) [NCBI Gene 158506] {aka CT138, HAKAIL, ZNF645}, CSDE1 (cold shock domain containing E1) [NCBI Gene 7812] {aka D1S155E, UNR}, G3BP1 (G3BP stress granule assembly factor 1) [NCBI Gene 10146] {aka G3BP, HDH-VIII}, Rbp4 (retinol binding protein 4, plasma) [NCBI Gene 19662] {aka Rbp-4}, ATP2A1 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1) [NCBI Gene 487] {aka ATP2A, SERCA1}, KDM4C (lysine demethylase 4C) [NCBI Gene 23081] {aka GASC1, JHDM3C, JMJD2C, TDRD14C}, Hal (histidine ammonia lyase) [NCBI Gene 15109] {aka Hsd, his, histidase}, Myc (Myc proto-oncogene, bHLH transcription factor) [NCBI Gene 17869] {aka Myc2, Niard, Nird, bHLHe39}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Hnrnpul2 (heterogeneous nuclear ribonucleoprotein U-like 2) [NCBI Gene 68693] {aka 1110031M08Rik, Hnrpul2}
- **Diseases:** neuropsychiatric conditions (MESH:D001523), impairments in neurodevelopment (MESH:D060825), autism (MESH:D001321), anxiety (MESH:D001007), neurodegenerative (MESH:D019636), ASD (MESH:D000067877), Alzheimer's, and Parkinson's) disorders (MESH:D010300), neurological disorders (MESH:D009461), neuroblastoma (MESH:D009447), LLPS (MESH:D000210), synaptic abnormalities (MESH:D012183), neurological diseases (MESH:D020271), synaptic plasticity deficits (MESH:D010411), social abnormalities (MESH:D000067404), embryonic lethality (MESH:D020964), Rett syndrome (MESH:D015518), neurodevelopmental (MESH:D008607), neurodevelopmental disorder (MESH:D002658), ALS (MESH:D008113), cortical malformation (MESH:D054220)
- **Chemicals:** NP-40 (MESH:C010615), polyethylenimine (MESH:D011094), EDTA (MESH:D004492), VCR (MESH:D014750), IP (MESH:C041508), streptomycin (MESH:D013307), MgCl2 (MESH:D015636), NaCl (MESH:D012965), salt (MESH:D012492), TCEP (MESH:C080938), DTT (MESH:D004229), SDS (MESH:D012967), imidazole (MESH:C029899), NT2 (MESH:C068951), Trizol (MESH:C411644), sodium arsenite (MESH:C017947), urea (MESH:D014508), 2xSDS (-), GST (MESH:C059555), HEPES (MESH:D006531), Glycerol (MESH:D005990), puromycin (MESH:D011691), penicillin (MESH:D010406), PBS (MESH:D007854), NEM (MESH:C058866), KCl (MESH:D011189), Lys (MESH:D008239), PVDF (MESH:C024865), chloramphenicol (MESH:D002701), glucose (MESH:D005947), ampicillin (MESH:D000667), IPTG (MESH:D007544), CO2 (MESH:D002245), Glutathione (MESH:D005978), Sepharose4B (MESH:D012685), His6 (MESH:C471213)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606], Xenopus laevis (African clawed frog, species) [taxon 8355]
- **Mutations:** K-to-R, K208R, K727, 208R, K91R, p.C124W, K727R, 727R, K81, K333R, K208, K135R, Cys-His, K246R, K81R
- **Cell lines:** HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), BL21 E. coli — Homo sapiens (Human), EBV-related Burkitt lymphoma, Cancer cell line (CVCL_M639), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932526/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932526/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932526/full.md

---
Source: https://tomesphere.com/paper/PMC12932526